Venus flytrap (Dionaea muscipula solander ex ellis) contains powerful compounds that prevent and cure cancer

Frontiers in Oncology

Volumn 3 AUG, Issue , 2013, Pages

  Gaascht, François ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Chemoprevention; Dionaea; Natural compound; Therapy

Indexed keywords

CAFFEIC ACID; CHLOROGENIC ACID; DOXORUBICIN; ELLAGIC ACID; FERULIC ACID; FLAVONOID; FLUOROURACIL; GALLIC ACID; GELATINASE B; GENISTEIN; KAEMPFEROL; MYRICETIN; NAPHTHOQUINONE; PHENOL DERIVATIVE; PLUMBAGIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTOCATECHUIC ACID; QUERCETIN; REACTIVE OXYGEN METABOLITE; RUTOSIDE; SALICYLIC ACID; SINAPIC ACID; SULINDAC; SYRINGIC ACID; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VANILLIC ACID; VANILLIN;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CARNIVOROUS PLANT; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; DIONAEA MUSCIPULA; FOLLICULAR LYMPHOMA; HUMAN; NEOPLASM; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PLANT ROOT; PROSTATE CANCER; PROTEIN EXPRESSION; SKIN TUMOR; STOMACH ADENOCARCINOMA; TRADITIONAL MEDICINE;

EID: 84891135766     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00202     Document Type: Article

References (272)

1. Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol (2010) 46:308-16. doi:10.1007/s12033-010-9321-2
2. Liu FS. Mechanisms of chemotherapeutic drug resistance in cancer therapy-a quick review. Taiwan J Obstet Gynecol (2009) 48:239-44. doi:10.1016/S1028-4559(09)60296-5
3. Morens DM, Fauci AS. Emerging infectious diseases in 2012: 20 years after the institute of medicine report. MBio (2012) 3. doi:10.1128/mBio.00494-12
4. Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta (2013). 1830:3670-95. doi:10.1016/j.bbagen.2013.02.008
5. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod (2012) 75:311-35. doi:10.1021/np200906s
6. Bourgaud F, Gravot A, Milesi S, Gontier E. Production of plant secondary metabolites: a historical perspective. Plant Sci (2001) 161:839-51. doi:10.1016/S0168-9452(01)00490-3
7. Craik DJ. Host-defense activities of cyclotides. Toxins (2012) 4:139-56. doi:10.3390/toxins4020139
8. Hartmann T. From waste products to ecochemicals: fifty years research of plant secondary metabolism. Phytochemistry (2007) 68:2831-46. doi:10.1016/j.phytochem.2007.09.017
9. Heinen TE, da Veiga AB. Arthropod venoms and cancer. Toxicon (2011) 57:497-511. doi:10.1016/j.toxicon.2011.01.002
10. Jain D, Kumar S. Snake venom: a potent anticancer agent. Asian Pac J Cancer Prev (2012) 13:4855-60. doi:10.7314/APJCP.2012.13.10.4855
11. Namdeo A. (2007). Plant cell elicitation for production of secondary metabolites: a review. Phcog Rev (2007) 1:69-79.
12. Schmidt EW, Donia MS, McIntosh JA, Fricke WF, Ravel J. Origin and variation of tunicate secondary metabolites. J Nat Prod (2012) 75:295-304. doi:10.1021/np200665k
13. Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol (2009) 27:2712-25. doi:10.1200/JCO.2008.20.6235
14. Kreher B, Neszmélyi A, Wagner H. Naphthoquinones from Dionaea muscipula. Phytochemistry (1990) 29:605-6. doi:10.1016/0031-9422(90)85125-Y
15. Gaascht F, Teiten MH, Schumacher M, Dicato M, Diederich M. Approche végétale dans le traitement des leucémies. Corresp Onco-Hématol (2010) V:102-8.
16. Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, et al. Cancer prevention with natural compounds. Semin Oncol (2010) 37:258-81. doi:10.1053/j.seminoncol.2010.06.014
17. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer (2003) 3:768-80. doi:10.1038/nrc1189
18. Schumacher M, Kelkel M, Dicato M, Diederich M. Gold from the sea: marine compounds as inhibitors of the hallmarks of cancer. Biotechnol Adv (2011) 29:531-47. doi:10.1016/j.biotechadv.2011.02.002
19. Teiten MH, Gaascht F, Dicato M, Diederich M. Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents. Curr Pharm Biotechnol (2012) 13:245-54. doi:10.2174/138920112798868593
20. Kelkel M, Jacob C, Dicato M, Diederich M. Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies. Molecules (2010) 15:7035-74. doi:10.3390/molecules15107035
21. Bishayee A, Politis T, Darvesh AS. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev (2010) 36:43-53. doi:10.1016/j.ctrv.2009.10.002
22. Kraft TE, Parisotto D, Schempp C, Efferth T. Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr (2009) 49:782-99. doi:10.1080/10408390802248627
23. Martin MA, Goya L, Ramos S. Potential for preventive effects of cocoa and cocoa polyphenols in cancer. Food Chem Toxicol (2013) 56:336-51. doi:10.1016/j.fct.2013.02.020
24. Maskarinec G. Cancer protective properties of cocoa: a review of the epidemiologic evidence. Nutr Cancer (2009) 61:573-9. doi:10.1080/01635580902825662
25. Khalil MI, Sulaiman SA. The potential role of honey and its polyphenols in preventing heart diseases: a review. Afri J Tradit Complement Altern Med (2010) 7:315-21.
26. Sawadogo WR, Schumacher M, Teiten MH, Dicato M, Diederich M. Traditional West African pharmacopeia, plants and derived compounds for cancer therapy. Biochem Pharmacol (2012) 84:1225-40. doi:10.1016/j.bcp.2012.07.021
27. Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, et al. Natural compounds for cancer treatment and prevention. Pharmacol Res (2009) 59:365-78. doi:10.1016/j.phrs.2009.01.017
28. Orlikova B, Diederich M. Power from the garden: plant compounds as inhibitors of the hallmarks of cancer. Curr Med Chem (2012) 19:2061-87. doi:10.2174/092986712800228998
29. Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med (2007) 13:353-61. doi:10.1016/j.molmed.2007.07.001
30. Folmer F, Jaspars M, Dicato M, Diederich M. Marine natural products as targeted modulators of the transcription factor NF-kappaB. Biochem Pharmacol (2008) 75:603-17. doi:10.1016/j.bcp.2007.07.044
31. Senevirathne M, Kim SK. Utilization of seafood processing by-products: medicinal applications. Adv Food Nutr Res (2012) 65:495-512. doi:10.1016/B978-0-12-416003-3.00032-9
32. Zhou ZF, Guo YW. Bioactive natural products from Chinese marine flora and fauna. Acta Pharmacol Sin (2012) 33:1159-69. doi:10.1038/aps.2012.110
33. Mayer AM, Gustafson KR. Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds. Eur J Cancer (2008) 44:2357-87. doi:10.1016/j.ejca.2008.07.001
34. Molinski TF, Dalisay DS, Lievens SL, Saludes JP. Drug development from marine natural products. Nat Rev Drug Discov (2009) 8:69-85. doi:10.1038/nrd2487
35. Ellingwood F, Lloyd JU. American Materia Medica, Therapeutics and Pharmacognosy: Developing the Latest Acquired Knowledge of Drugs, and Especially of the Direct Action of Single Drugs Upon Exact Conditions of Disease, with Especial Reference to the Therapeutics of the Plant Drugs of the Americas. Chicago: Ellingwood's therapeutist (1919). 542 p.
36. Lloyd J, Felter H. King's American Dispensatory. 18th ed. Sandy, OR: Eclectic Medical Publications (1898).
37. Moerman DE. Native American Ethnobotany Database. Portland: Timber Press, Inc (1998). 927 p.
38. Remington JP. The Dispensatory of the United States of America. Philadelphia: Lippincott (1918). 2010 p.
39. Muhammad A, Guerrero-Analco JA, Martineau LC, Musallam L, Madiraju P, Nachar A, et al. Antidiabetic compounds from Sarracenia purpurea used traditionally by the Eeyou Istchee Cree First Nation. J Nat Prod (2012) 75:1284-8. doi:10.1021/np3001317
40. Renshaw CJ. Treatment of small-pox by Sarracenia Purpurea. BMJ (1863) 1:127-127. doi:10.1136/bmj.1.109.127
41. Behera KK, Sahoo S, Mohapatra PC. Medicinal plant resources for bioprospecting and drug development in tribal rich district of Orissa, India. Ethnobot Leafl (2007) 11:106-12.
42. Kayang H, Kharbuli B, Myrboh B, Syiem D. Medicinal plants of Khasi hills of Meghalaya, India. In: Bernáth ENJ, Craker LE, Gardner ZE, editors. III WOCMAP Congress on Medicinal and Aromatic Plants-Volume 1: Bioprospecting and Ethnopharmacology. Chiang Mai: Acta Horticulturae (2003). p. 75-80.
43. Kumar S. The Medicinal Plants of North-East India. Jodhpur: Scientific Publishers (2002). 212 p.
44. Prasad MNV, Jeeva S. Coal mining and its leachate are potential threats to Nepenthes khasiana Hook. f.(Nepenthaceae) that preys on insects-an endemic plant in North Eastern India. Biol Div Con (2009) 2:29-33.
45. Shin KS, Lee S, Cha BJ. Suppression of phytopathogenic fungi by hexane extract of Nepenthes ventricosa x maxima leaf. Fitoterapia (2007) 78:585-6. doi:10.1016/j.fitote.2007.03.020
46. Singh J, Mudgal V. Studies on habitat conditions of a few plants species of medicinal values of Nokrek Biosphere Reserve, Meghalaya. J Non-Timber For Products (1999) 6:4.
47. Volkov AG, Murphy VA, Clemmons JI, Curley MJ, Markin VS. Energetics and forces of the Dionaea muscipula trap closing. J Plant Physiol (2012) 169:55-64. doi:10.1016/j.jplph.2011.08.003
48. Volkov AG, Harris SL 2nd, Vilfranc CL, Murphy VA, Wooten JD, Paulicin H, et al. Venus flytrap biomechanics: forces in the Dionaea muscipula trap. J Plant Physiol (2013) 170:25-32. doi:10.1016/j.jplph.2012.08.009
49. Volkov AG, Adesina T, Markin VS, Jovanov E. Kinetics and mechanism of Dionaea muscipula trap closing. Plant Physiol (2008) 146:694-702. doi:10.1104/pp.107.108241
50. Schulze WX, Sanggaard KW, Kreuzer I, Knudsen AD, Bemm F, Thogersen IB, et al. The protein composition of the digestive fluid from the venus flytrap sheds light on prey digestion mechanisms. Mol Cell Proteomics (2012) 11:1306-19. doi:10.1074/mcp.M112.021006
51. Adlassnig W, Koller-Peroutka M, Bauer S, Koshkin E, Lendl T, Lichtscheidl IK. Endocytotic uptake of nutrients in carnivorous plants. Plant J (2012) 71:303-13. doi:10.1111/j.1365-313X.2012.04997.x
52. Krol E, Plachno BJ, Adamec L, Stolarz M, Dziubinska H, Trebacz K. Quite a few reasons for calling carnivores 'the most wonderful plants in the world.' Ann Bot (Lond) (2012) 109:47-64. doi:10.1093/aob/mcr249
53. Scala J, Iott K, Schwab DW, Semersky FE. Digestive secretion of Dionaea muscipula (Venus's Flytrap). Plant Physiol (1969) 44:367-71. doi:10.1104/pp.44.3.367
54. Kovacik J, Klejdus B, Repcakova K. Phenolic metabolites in carnivorous plants: inter-specific comparison and physiological studies. Plant Physiol Biochem (2012) 52:21-7. doi:10.1016/j.plaphy.2011.11.007
55. Krolicka A, Szpitter A, Gilgenast E, Romanik G, Kaminski M, Lojkowska E. Induction of naphthoquinone and flavonoid production in Dionaea muscipula and Drosera capensis. Planta Med (2006) 72:137.
56. Nagata T, Ebizuka Y. Medicinal and Aromatic Plants XII. Dordrecht: Springer (2002). 348 p.
57. Pakulski G, Budzianowski J. Ellagic acid derivatives and naphthoquinones of Dionaea muscipula from in vitro cultures. Phytochemistry (1996) 41:775-8. doi:10.1016/0031-9422(96)89675-0
58. Tokunaga T, Takada N, Ueda M. Mechanism of antifeedant activity of plumbagin, a compound concerning the chemical defense in carnivorous plant. Tetrahedron Lett (2004) 45:7115-9. doi:10.1016/j.tetlet.2004.07.094
59. Hsieh Y-J, Lin L-C, Tsai T-H Determination and identification of plumbagin from the roots of Plumbago zeylanica L. by liquid chromatography with tandem mass spectrometry. J Chromatogr A (2005) 1083:141-5. doi:10.1016/j.chroma.2005.06.030
60. Bashir A, Abdalla A, Wasfi I, Hassan E, Amiri M, Crabb T. Flavonoids of Limonium axillare. Pharm Biol (1994) 32:366-72. doi:10.3109/13880209409083017
61. Binder RG, Benson ME, Flath RA. Eight 1, 4-naphthoquinones from Juglans. Phytochemistry (1989) 28:2799-801. doi:10.1016/S0031-9422(00)98092-0
62. Hedin PA, Collum DH, Langhans VE, Graves CH. Distribution of juglone and related compounds in pecan and their effect on Fusicladium effusum. J Agric Food Chem (1980) 28:340-2. doi:10.1021/jf60228a026
63. Raj G, Kurup R, Hussain AA, Baby S. Distribution of naphthoquinones, plumbagin, droserone, and 5-O-methyl droserone in chitin-induced and uninduced Nepenthes khasiana: molecular events in prey capture. J Exp Bot (2011) 62:5429-36. doi:10.1093/jxb/err219
64. Aung HH, Chia LS, Goh NK, Chia TF, Ahmed AA, Pare PW, et al. Phenolic constituents from the leaves of the carnivorous plant Nepenthes gracilis. Fitoterapia (2002) 73:445-7. doi:10.1016/S0367-326X(02)00113-2
65. Kawiak A, Piosik J, Stasilojc G, Gwizdek-Wisniewska A, Marczak L, Stobiecki M, et al. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II. Toxicol Appl Pharmacol (2007) 223:267-76. doi:10.1016/j.taap.2007.05.018
66. Acharya BR, Bhattacharyya B, Chakrabarti G. The natural naphthoquinone plumbagin exhibits antiproliferative activity and disrupts the microtubule network through tubulin binding. Biochemistry (2008) 47:7838-45. doi:10.1021/bi800730q
67. Hsu YL, Cho CY, Kuo PL, Huang YT, Lin CC. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp Ther (2006) 318:484-94. doi:10.1124/jpet.105.098863
68. Sandur SK, Ichikawa H, Sethi G, Ahn KS, Aggarwal BB. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem (2006) 281:17023-33.
69. Li L, Huang J, Xu X, Zhang Y, Cheng K, Yu P. Study on chemical constituents of Drosera peltata var. multisepala. Zhongguo Zhong Yao Za Zhi (2012) 37:222-5.
70. Gu JQ, Graf TN, Lee D, Chai HB, Mi Q, Kardono LB, et al. Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia. J Nat Prod (2004) 67:1156-61. doi:10.1021/np040027m
71. Lin LC, Yang LL, Chou CJ. Cytotoxic naphthoquinones and plumbagic acid glucosides from Plumbago zeylanica. Phytochemistry (2003) 62:619-22. doi:10.1016/S0031-9422(02)00519-8
72. Whitson EL, Sun H, Thomas CL, Henrich CJ, Sayers TJ, McMahon JB, et al. Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima. J Nat Prod (2012) 75:394-9. doi:10.1021/np200805z
73. Budzianowski J, Budzianowska A, Kromer K. Naphthalene glucoside and other phenolics from the shoot and callus cultures of Drosophyllum lusitanicum. Phytochemistry (2002) 61:421-5. doi:10.1016/S0031-9422(02)00258-3
74. Bringmann G, Rischer H, Wohlfarth M, Schlauer J, Assi LA. Droserone from cell cultures of Triphyophyllum peltatum (Dioncophyllaceae) and its biosynthetic origin. Phytochemistry (2000) 53:339-43. doi:10.1016/S0031-9422(99)00543-9
75. Sidhu G, Sankaram A. A new biplumbagin and 3-chloroplumbagin from Plumbago zeylanica. Tetrahedron Lett (1971) 12:2385-8. doi:10.1016/S0040-4039(01)96870-4
76. Likhitwitayawuid K, Kaewamatawong R, Ruangrungsi N, Krungkrai J. Antimalarial naphthoquinones from Nepenthes thorelii. Planta Med (1998) 64:237-41. doi:10.1055/s-2006-957417
77. Miyoshi E, Shizuri Y, Yamamura S. Isolation and structures of diomuscinone and diomuscipulone from Dionaea muscipula. Phytochemistry (1984) 23:2385-7. doi:10.1016/S0031-9422(00)80563-4
78. Salae A-W, Karalai C, Ponglimanont C, Kanjana-Opas A, Yuenyongsawad S. Naphthalene derivatives from Diospyros wallichii. Can J Chem (2010) 88:922-7. doi:10.1139/V10-084
79. Aguilera-Carbo A, Augur C, Prado-Barragan L, Aguilar C, Favela-Torres E. Extraction and analysis of ellagic acid from novel complex sources. Chem Papers (2008) 62:440-4. doi:10.2478/s11696-008-0042-y
80. Cardona JA, Lee JH, Talcott ST. Color and polyphenolic stability in extracts produced from muscadine grape (Vitis rotundifolia) pomace. J Agric Food Chem (2009) 57:8421-5. doi:10.1021/jf901840t
81. Huang WY, Zhang HC, Liu WX, Li CY. Survey of antioxidant capacity and phenolic composition of blueberry, blackberry, and strawberry in Nanjing. J Zhejiang Univ Sci B (2012) 13:94-102. doi:10.1631/jzus.B1100137
82. Pellati F, Bruni R, Righi D, Grandini A, Tognolini M, Pio Prencipe F, et al. Metabolite profiling of polyphenols in a Terminalia chebula Retzius ayurvedic decoction and evaluation of its chemopreventive activity. J Ethnopharmacol (2013) 147:277-85. doi:10.1016/j.jep.2013.02.025
83. Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Go VL, Pandol SJ, et al. Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol (2008) 14:3672-80. doi:10.3748/wjg.14.3672
84. Malik A, Afaq S, Shahid M, Akhtar K, Assiri A. Influence of ellagic acid on prostate cancer cell proliferation: a caspase-dependent pathway. Asian Pac J Trop Med (2011) 4:550-5. doi:10.1016/S1995-7645(11)60144-2
85. Tan KW, Li Y, Paxton JW, Birch NP, Scheepens A. Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Food Chem (2013) 138:2267-74. doi:10.1016/j.foodchem.2012.12.021
86. Karimi E, Oskoueian E, Hendra R, Oskoueian A, Jaafar HZ. Phenolic compounds characterization and biological activities of Citrus aurantium bloom. Molecules (2012) 17:1203-18. doi:10.3390/molecules17021203
87. Lai TN, Herent MF, Quetin-Leclercq J, Nguyen TB, Rogez H, Larondelle Y, et al. Piceatannol, a potent bioactive stilbene, as major phenolic component in Rhodomyrtus tomentosa. Food Chem (2013) 138:1421-30. doi:10.1016/j.foodchem.2012.10.125
88. Sultana N, Akhter M, Khatoon Z. Nematicidal natural products from the aerial parts of Rubus niveus. Nat Prod Res (2010) 24:407-15. doi:10.1080/14786410802696429
89. Verma S, Singh A, Mishra A. Gallic acid: molecular rival of cancer. Environ Toxicol Pharmacol (2013) 35:473-85. doi:10.1016/j.etap.2013.02.011
90. Weidner S, Rybarczyk A, Karamac M, Krol A, Mostek A, Grebosz J, et al. Differences in the phenolic composition and antioxidant properties between Vitis coignetiae and Vitis vinifera seeds extracts. Molecules (2013) 18:3410-26. doi:10.3390/molecules18033410
91. Chandramohan Reddy T, Bharat Reddy D, Aparna A, Arunasree KM, Gupta G, Achari C, et al. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-kappaB inactivation. Toxicol In vitro (2012) 26:396-405. doi:10.1016/j.tiv.2011.12.018
92. León-González AJ, Truchado P, Tomás-Barberán FA, López-Lázaro M, Barradas MCD, Martín-Cordero C. Phenolic acids, flavonols and anthocyanins in Corema album (L.) D. Don berries. J Food Compost Anal (2013) 29:58-63. doi:10.1016/j.jfca.2012.10.003
93. Ao C, Li A, Elzaawely AA, Xuan TD, Tawata S. Evaluation of antioxidant and antibacterial activities of Ficus microcarpa L. fil. extract. Food Control (2008) 19:940-8. doi:10.1016/j.foodcont.2007.09.007
94. Cottle W, Kolattukudy PE. Biosynthesis, deposition, and partial characterization of potato suberin phenolics. Plant Physiol (1982) 69:393-9. doi:10.1104/pp.69.2.393
95. Lirdprapamongkol K, Sakurai H, Kawasaki N, Choo MK, Saitoh Y, Aozuka Y, et al. Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci (2005) 25:57-65. doi:10.1016/j.ejps.2005.01.015
96. Lirdprapamongkol K, Sakurai H, Suzuki S, Koizumi K, Prangsaengtong O, Viriyaroj A, et al. Vanillin enhances TRAIL-induced apoptosis in cancer cells through inhibition of NF-kappaB activation. In vivo (2010) 24:501-6.
97. Lirdprapamongkol K, Kramb JP, Suthiphongchai T, Surarit R, Srisomsap C, Dannhardt G, et al. Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in vivo. J Agric Food Chem (2009) 57:3055-63. doi:10.1021/jf803366f
98. Shahidi F, Perera N. Oil and phytochemicals from small fruit seeds. In: Chi-Tang Ho CM, Shahidi F, Contis ET, editors. Nutrition, Functional and Sensory Properties of Foods. Cambridge: RSC Publishing (2013). p. 224-30.
99. Hudson EA, Dinh PA, Kokubun T, Simmonds MS, Gescher A. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev (2000) 9:1163-70.
100. Chen FF, Wang GY, Shi YP. Molecularly imprinted polymer microspheres for solid-phase extraction of protocatechuic acid in Rhizoma homalomenae. J Sep Sci (2011) 34:2602-10. doi:10.1002/jssc.201100463
101. Lin HH, Chen JH, Wang CJ. Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus sabdariffa Linne. Curr Med Chem (2011) 18:1245-54. doi:10.2174/092986711795029663
102. Qing ZJ, Yong W, Hui LY, Yong LW, Long LH, Ao DJ, et al. Two new natural products from the fruits of Alpinia oxyphylla with inhibitory effects on nitric oxide production in lipopolysaccharide-activated RAW264.7 macrophage cells. Arch Pharm Res (2012) 35:2143-6. doi:10.1007/s12272-012-1211-7
103. Tang RN, Qu XB, Guan SH, Xu PP, Shi YY, Guo DA. Chemical constituents of Spatholobus suberectus. Chin J Nat Med (2012) 10:32-5. doi:10.3724/SP.J.1009.2012.00032
104. Lin HH, Chen JH, Chou FP, Wang CJ. Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-kappaB pathway and MMP-2 production by targeting RhoB activation. Br J Pharmacol (2011) 162:237-54. doi:10.1111/j.1476-5381.2010.01022.x
105. Anter J, Romero-Jimenez M, Fernandez-Bedmar Z, Villatoro-Pulido M, Analla M, Alonso-Moraga A, et al. Antigenotoxicity, cytotoxicity, and apoptosis induction by apigenin, bisabolol, and protocatechuic acid. J Med Food (2011) 14:276-83. doi:10.1089/jmf.2010.0139
106. Scognamiglio M, Esposito A, D'Abrosca B, Pacifico S, Fiumano V, Tsafantakis N, et al. Isolation, distribution and allelopathic effect of caffeic acid derivatives from Bellis perennis L. Biochem Syst Ecol (2012) 43:108-13. doi:10.1016/j.bse.2012.02.025
107. Rajendra Prasad N, Karthikeyan A, Karthikeyan S, Reddy BV. Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem (2011) 349:11-9. doi:10.1007/s11010-010-0655-7
108. Moon MK, Lee YJ, Kim JS, Kang DG, Lee HS. Effect of caffeic acid on tumor necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells. Biol Pharm Bull (2009) 32:1371-7. doi:10.1248/bpb.32.1371
109. Jaganathan SK. Growth inhibition by caffeic acid, one of the phenolic constituents of honey, in HCT 15 colon cancer cells. ScientificWorldJournal (2012) 2012:372345. doi:10.1100/2012/372345
110. Bouayed J, Rammal H, Dicko A, Younos C, Soulimani R. Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects. J Neurol Sci (2007) 262:77-84. doi:10.1016/j.jns.2007.06.028
111. Moores R, McDermott DL, Wood T. Determination of chlorogenic acid in coffee. Anal Chem (1948) 20:620-4. doi:10.1021/ac60019a007
112. Zhang B, Yang R, Liu C-Z. Microwave-assisted extraction of chlorogenic acid from flower buds of Lonicera japonica Thunb. Sep Purif Technol (2008) 62:480-3. doi:10.1016/j.seppur.2008.02.013
113. Yang J-S, Liu C-W, Ma Y-S, Weng S-W, Tang N-Y, Wu S-H, et al. Chlorogenic acid induces apoptotic cell death in U937 leukemia cells through caspase-and mitochondria-dependent pathways. In vivo (2012) 26:971-8.
114. Graf E. Antioxidant potential of ferulic acid. Free Radic Biol Med (1992) 13:435-48. doi:10.1016/0891-5849(92)90184-I
115. Hayat S, Ali B, Ahmad A. Salicylic acid: biosynthesis, metabolism and physiological role in plants. In: Hayat S, Ahmad A, editors. Salicylic Acid: A Plant Hormone. Dordrecht: Springer (2007). p. 1-14.
116. Zitta K, Meybohm P, Bein B, Huang Y, Heinrich C, Scholz J, et al. Salicylic acid induces apoptosis in colon carcinoma cells grown in-vitro: influence of oxygen and salicylic acid concentration. Exp Cell Res (2012) 318:828-34. doi:10.1016/j.yexcr.2012.02.002
117. Spitz GA, Furtado CM, Sola-Penna M, Zancan P. Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem Pharmacol (2009) 77:46-53. doi:10.1016/j.bcp.2008.09.020
118. Afify Ael M, El-Beltagi HS, El-Salam SM, Omran AA. Biochemical changes in phenols, flavonoids, tannins, vitamin E, beta-carotene and antioxidant activity during soaking of three white sorghum varieties. Asian Pac J Trop Biomed (2012) 2:203-9. doi:10.1016/S2221-1691(12)60042-2
119. Abaza MS, Al-Attiyah R, Bhardwaj R, Abbadi G, Koyippally M, Afzal M. Syringic acid from Tamarix aucheriana possesses antimitogenic and chemo-sensitizing activities in human colorectal cancer cells. Pharm Biol (2013). doi:10.3109/13880209.2013.781194. [Epub ahead of print].
120. Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, et al. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res (2004) 6:R63-74. doi:10.1186/bcr752
121. Muhammad A, Haddad PS, Durst T, Arnason JT. Phytochemical constituents of Sarracenia purpurea L. (pitcher plant). Phytochemistry (2013). doi:10.1016/j.phytochem.2013.05.015. [Epub ahead of print].
122. Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun (2005) 328:227-34. doi:10.1016/j.bbrc.2004.12.151
123. Shan BE, Wang MX, Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest (2009) 27:604-12. doi:10.1080/07357900802337191
124. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur J Pharmacol (2010) 649:84-91. doi:10.1016/j.ejphar.2010.09.020
125. Bishayee K, Ghosh S, Mukherjee A, Sadhukhan R, Mondal J, Khuda-Bukhsh AR. Quercetin induces cytochrome-c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2/M, in cervical carcinoma: signal cascade and drug-DNA interaction. Cell Prolif (2013) 46:153-63. doi:10.1111/cpr.12017
126. Kang JW, Kim JH, Song K, Kim SH, Yoon JH, Kim KS. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res (2010) 24(Suppl 1):S77-82. doi:10.1002/ptr.2913
127. Pakulski G, Budzianowski J. Quercetin and kaempferol glycosides of Dionaea muscipula from in vitro cultures. Planta Med (1996) 62:95-6. doi:10.1055/s-2006-957824
128. Hakkinen SH, Karenlampi SOI, Heinonen M, Mykkanen HM, Torronen AR. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem (1999) 47:2274-9. doi:10.1021/jf9811065
129. Oskoueian E, Abdullah N, Ahmad S, Saad WZ, Omar AR, Ho YW. Bioactive compounds and biological activities of Jatropha curcas L. kernel meal extract. Int J Mol Sci (2011) 12:5955-70. doi:10.3390/ijms12095955
130. Zwolak P, Borja-Cacho D, Phillips P, Dudeja V, Dawra RK, Talukdar R, et al. Myricetin a novel natural antineoplastic agent decreases progression of human pancreatic cancer via inhibition of Akt kinase and Erk pathways. J Surg Res (2008) 144:200-200. doi:10.1016/j.jss.2007.12.063
131. Sun F, Zheng XY, Ye J, Wu TT, Wang J, Chen W. Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo. Nutr Cancer (2012) 64:599-606. doi:10.1080/01635581.2012.665564
132. Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem (2011) 11:298-344. doi:10.2174/138955711795305335
133. Luo H, Rankin GO, Li Z, Depriest L, Chen YC. Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway. Food Chem (2011) 128:513-9. doi:10.1016/j.foodchem.2011.03.073
134. Luo H, Rankin GO, Juliano N, Jiang BH, Chen YC. Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFkappaB-cMyc-p21 pathway. Food Chem (2012) 130:321-8. doi:10.1016/j.foodchem.2011.07.045
135. Babula P, Adam V, Kizek R, Sladkỳ Z, Havel L. Naphthoquinones as allelochemical triggers of programmed cell death. Environ Exp Bot (2009) 65:330-7. doi:10.1016/j.envexpbot.2008.11.007
136. Babula P, Mikelova R, Adam V, Kizek R, Havel L, Sladky Z. Using of liquid chromatography coupled with diode array detector for determination of naphthoquinones in plants and for investigation of influence of pH of cultivation medium on content of plumbagin in Dionaea muscipula. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 842:28-35. doi:10.1016/j.jchromb.2006.05.009
137. Eilenberg H, Pnini-Cohen S, Rahamim Y, Sionov E, Segal E, Carmeli S, et al. Induced production of antifungal naphthoquinones in the pitchers of the carnivorous plant Nepenthes khasiana. J Exp Bot (2010) 61:911-22. doi:10.1093/jxb/erp359
138. Marczak L, Kawiak A, Lojkowska E, Stobiecki M. Secondary metabolites in in vitro cultured plants of the genus Drosera. Phytochem Anal (2005) 16:143-9. doi:10.1002/pca.833
139. Tilak JC, Adhikari S, Devasagayam TP. Antioxidant properties of Plumbago zeylanica, an Indian medicinal plant and its active ingredient, plumbagin. Redox Rep (2004) 9:219-27. doi:10.1179/135100004225005976
140. Kuo PL, Hsu YL, Cho CY. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther (2006) 5:3209-21. doi:10.1158/1535-7163.MCT-06-0478
141. Wang CC, Chiang YM, Sung SC, Hsu YL, Chang JK, Kuo PL. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett (2008) 259:82-98. doi:10.1016/j.canlet.2007.10.005
142. Gomathinayagam R, Sowmyalakshmi S, Mardhatillah F, Kumar R, Akbarsha MA, Damodaran C. Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Anticancer Res (2008) 28:785-92.
143. Yang SJ, Chang SC, Wen HC, Chen CY, Liao JF, Chang CH. Plumbagin activates ERK1/2 and Akt via superoxide, Src and PI3-kinase in 3T3-L1 cells. Eur J Pharmacol (2010) 638:21-8. doi:10.1016/j.ejphar.2010.04.016
144. Hafeez BB, Zhong W, Fischer JW, Mustafa A, Shi X, Meske L, et al. Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model. Mol Oncol (2013). 7:428-39. doi:10.1016/j.molonc.2012.12.001
145. Sinha S, Pal K, Elkhanany A, Dutta S, Cao Y, Mondal G, et al. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer (2013) 132:1201-12. doi:10.1002/ijc.27724
146. Thasni KA, Ratheeshkumar T, Rojini G, Sivakumar KC, Nair RS, Srinivas G, et al. Structure activity relationship of plumbagin in BRCA1 related cancer cells. Mol Carcinog (2013) 52:392-403. doi:10.1002/mc.21877
147. Lee JH, Yeon JH, Kim H, Roh W, Chae J, Park HO, et al. The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation. PLoS ONE (2012) 7:e45023. doi:10.1371/journal.pone.0045023
148. Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar FH. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev (2012) 32:1131-58. doi:10.1002/med.20235
149. Sun J, McKallip RJ. Plumbagin treatment leads to apoptosis in human K562 leukemia cells through increased ROS and elevated TRAIL receptor expression. Leuk Res (2011) 35:1402-8. doi:10.1016/j.leukres.2011.06.018
150. Shukla S, Wu CP, Nandigama K, Ambudkar SV. The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2. Mol Cancer Ther (2007) 6:3279-86. doi:10.1158/1535-7163.MCT-07-0564
151. Hsieh YJ, Lin LC, Tsai TH. Measurement and pharmacokinetic study of plumbagin in a conscious freely moving rat using liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 844:1-5. doi:10.1016/j.jchromb.2006.06.024
152. Higa M, Ogihara K, Yogi S. Bioactive naphthoquinone derivatives from Diospyros maritima Blume. Chem Pharm Bull (1998) 46:1189-93. doi:10.1248/cpb.46.1189
153. Lattanzio V, Lattanzio VM, Cardinali A. Role of phenolics in the resistance mechanisms of plants against fungal pathogens and insects. Phytochemistry (2006) 661:23-67.
154. Muller-Scharer H, Schaffner U, Steinger T. Evolution in invasive plants: implications for biological control. Trends Ecol Evol (2004) 19:417-22.
155. Wang Y, Siemann E, Wheeler GS, Zhu L, Gu X, Ding J. Genetic variation in anti-herbivore chemical defences in an invasive plant. J Ecol (2012) 100:894-904. doi:10.1111/j.1365-2745.2012.01980.x
156. Hancock V, Dahl M, Vejborg RM, Klemm P. Dietary plant components ellagic acid and tannic acid inhibit Escherichia coli biofilm formation. J Med Microbiol (2010) 59:496-8. doi:10.1099/jmm.0.013680-0
157. Quave CL, Estevez-Carmona M, Compadre CM, Hobby G, Hendrickson H, Beenken KE, et al. Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics. PLoS ONE (2012) 7:e28737. doi:10.1371/journal.pone.0028737
158. Umesalma S, Sudhandiran G. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol (2010) 107:650-5. doi:10.1111/j.1742-7843.2010.00565.x
159. Wang N, Wang ZY, Mo SL, Loo TY, Wang DM, Luo HB, et al. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Res Treat (2012) 134:943-55. doi:10.1007/s10549-012-1977-9
160. Atri N, Sharma SK, Joshi R, Gulati A, Gulati A. Nutritional and neutraceutical composition of five wild culinary-medicinal species of genus pleurotus (higher basidiomycetes) from northwest India. Int J Med Mushrooms (2013) 15:49-56. doi:10.1615/IntJMedMushr.v15.i1.60
161. Hamedeyazdan S, Fathiazad F, Sharifi S, Nazemiyeh H. Antiproliferative activity of Marrubium persicum extract in the MCF-7 human breast cancer cell line. Asian Pac J Cancer Prev (2012) 13:5843-8. doi:10.7314/APJCP.2012.13.11.5843
162. Xiao S, Zhang LF, Zhang X, Li SM, Xue FQ. Tracing antibacterial compounds from Acalypha australis Linn. by spectrum-effect relationships and semi-preparative high-performance liquid chromatography. J Sep Sci (2013) 36:1667-76. doi:10.1002/jssc.201201202
163. Chanwitheesuk A, Teerawutgulrag A, Kilburn JD, Rakariyatham N. Antimicrobial gallic acid from Caesalpinia mimosoides Lamk. Food Chem (2007) 100:1044-8. doi:10.1016/j.foodchem.2005.11.008
164. Nguyen DM, Seo DJ, Lee HBI, Kim S, Kim KY, Park RD, et al. Antifungal activity of gallic acid purified from Terminalia nigrovenulosa bark against Fusarium solani. Microb Pathog (2013) 56:8-15. doi:10.1016/j.micpath.2013.01.001
165. Ho HH, Chang CS, Ho WC, Liao SY, Lin WL, Wang CJ. Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-kappaB activity. Toxicol Appl Pharmacol (2013) 266:76-85. doi:10.1016/j.taap.2012.10.019
166. Raina K, Rajamanickam S, Deep G, Singh M, Agarwal R, Agarwal C. Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice. Mol Cancer Ther (2008) 7:1258-67. doi:10.1158/1535-7163.MCT-07-2220
167. Liang CZ, Zhang X, Li H, Tao YQ, Tao LJ, Yang ZR, et al. Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways. Cancer Biother Radiopharm (2012) 27:701-10. doi:10.1089/cbr.2012.1245
168. Hodgson JM, Morton LW, Puddey IB, Beilin LJ, Croft KD. Gallic acid metabolites are markers of black tea intake in humans. J Agric Food Chem (2000) 48:2276-80. doi:10.1021/jf000089s
169. Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr (2001) 131:1207-10.
170. Kaur B, Chakraborty D. Biotechnological and molecular approaches for vanillin production: a review. Appl Biochem Biotechnol (2013) 169:1353-72. doi:10.1007/s12010-012-0066-1
171. Lesage-Meessen L, Lomascolo A, Bonnin E, Thibault JF, Buleon A, Roller M, et al. A biotechnological process involving filamentous fungi to produce natural crystalline vanillin from maize bran. Appl Biochem Biotechnol (2002) 10(2-103):141-53. doi:10.1385/ABAB:102-103:1-6:141
172. Walton NJ, Narbad A, Faulds C, Williamson G. Novel approaches to the biosynthesis of vanillin. Curr Opin Biotechnol (2000) 11:490-6. doi:10.1016/S0958-1669(00)00125-7
173. Walton NJ, Mayer MJ, Narbad A. Vanillin. Phytochemistry (2003) 63:505-15. doi:10.1016/S0031-9422(03)00149-3
174. Boonchird C, Flegel TW. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans. Can J Microbiol (1982) 28:1235-41. doi:10.1139/m82-184
175. Yemis GP, Pagotto F, Bach S, Delaquis P. Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter species. J Food Prot (2011) 74:2062-9. doi:10.4315/0362-028X.JFP-11-230
176. Ho K, Yazan LS, Ismail N, Ismail M. Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin. Cancer Epidemiol (2009) 33:155-60. doi:10.1016/j.canep.2009.06.003
177. Beaudry F, Ross A, Lema PP, Vachon P. Pharmacokinetics of vanillin and its effects on mechanical hypersensitivity in a rat model of neuropathic pain. Phytother Res (2010) 24:525-30. doi:10.1002/ptr.2975
178. Strand LP, Scheline RR. The metabolism of vanillin and isovanillin in the rat. Xenobiotica (1975) 5:49-63. doi:10.3109/00498257509056093
179. Tanaka T, Tanaka T, Tanaka M. Potential cancer chemopreventive activity of protocatechuic acid. J Exp Clin Med (2011) 3:27-33.
180. Yip EC, Chan AS, Pang H, Tam YK, Wong YH. Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism. Cell Biol Toxicol (2006) 22:293-302. doi:10.1007/s10565-006-0082-4
181. Aziz NH, Farag SE, Mousa LA, Abo-Zaid MA. Comparative antibacterial and antifungal effects of some phenolic compounds. Microbios (1998) 93:43-54.
182. Sato Y, Itagaki S, Kurokawa T, Ogura J, Kobayashi M, Hirano T, et al. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int J Pharm (2011) 403:136-8. doi:10.1016/j.ijpharm.2010.09.035
183. Lee WJ, Zhu BT. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis (2006) 27:269-77. doi:10.1093/carcin/bgi206
184. Azuma K, Ippoushi K, Nakayama M, Ito H, Higashio H, Terao J. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J Agric Food Chem (2000) 48:5496-500. doi:10.1021/jf000483q
185. Gonthier MP, Verny MA, Besson C, Remesy C, Scalbert A. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr (2003) 133:1853-9.
186. Olthof MR, Hollman PC, Katan MB. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr (2001) 131:66-71.
187. Peppercorn MA, Goldman P. Caffeic acid metabolism by bacteria of the human gastrointestinal tract. J Bacteriol (1971) 108:996-1000.
188. Hulme AC. The isolation of chlorogenic acid from the apple fruit. Biochem J (1953) 53:337-40.
189. Li H, Chen B, Yao S. Application of ultrasonic technique for extracting chlorogenic acid from Eucommia ulmodies Oliv. (E. ulmodies). Ultrason Sonochem (2005) 12:295-300. doi:10.1016/j.ultsonch.2004.01.033
190. Stacewicz-Sapuntzakis M, Bowen PE, Hussain EA, Damayanti-Wood BI, Farnsworth NR. Chemical composition and potential health effects of prunes: a functional food? Crit Rev Food Sci Nutr (2001) 41:251-86. doi:10.1080/20014091091814
191. Friend J, Reynolds S, Aveyard MA. Phenylalanine ammonia lyase, chlorogenic acid and lignin in potato tuber tissue inoculated with Phytophthora infestans. Physiol Plant Pathol (1973) 3:495-507. doi:10.1016/0048-4059(73)90060-X
192. Hoover K, Alaniz SA, Yee JL, Rocke DM, Hammock BD, Duffey SS. Dietary protein and chlorogenic acid effect on baculoviral disease of noctuid (Lepidoptera: Noctuidae) larvae. Environ Entomol (1998) 27:1264-72.
193. Ikonen A, Tahvanainen J, Roininen H. Chlorogenic acid as an antiherbivore defence of willows against leaf beetles. Entomol Exp Appl (2001) 99:47-54. doi:10.1046/j.1570-7458.2001.00800.x
194. Leiss KA, Maltese F, Choi YH, Verpoorte R, Klinkhamer PG. Identification of chlorogenic acid as a resistance factor for thrips in chrysanthemum. Plant Physiol (2009) 150:1567-75. doi:10.1104/pp.109.138131
195. Thurow T, Lee S-O. Effect of chlorogenic acid and neochlorogenic acid on human colon cancer cells. Disc J (2012) 13:86-93.
196. Burgos-Moron E, Calderon-Montano JM, Orta ML, Pastor N, Perez-Guerrero C, Austin C, et al. The coffee constituent chlorogenic acid induces cellular DNA damage and formation of topoisomerase I-and II-DNA complexes in cells. J Agric Food Chem (2012). doi:10.1021/jf300999e
197. Rathod MA, Patel D, Das A, Tipparaju SR, Shinde SS, Anderson RF. Inhibition of radical-induced DNA strand breaks by water-soluble constituents of coffee; phenolics and caffeine metabolites. Free Radic Res (2013) 47:480-7. doi:10.3109/10715762.2013.788167
198. Li ZH, Wang Q, Ruan X, Pan CD, Jiang DA. Phenolics and plant allelopathy. Molecules (2010) 15:8933-52. doi:10.3390/molecules15128933
199. Palacio L, Cantero JJ, Cusido RM, Goleniowski ME. Phenolic compound production in relation to differentiation in cell and tissue cultures of Larrea divaricata (Cav.). Plant Sci (2012) 19(3-194):1-7. doi:10.1016/j.plantsci.2012.05.007
200. Rasmussen JA, Einhellig FA. Synergistic inhibitory effects of p-coumaric and ferulic acids on germination and growth of grain sorghum. J Chem Ecol (1977) 3:197-205. doi:10.1007/BF00994146
201. Smith BG, Harris PJ. Ferulic acid is esterified to glucuronoarabinoxylans in pineapple cell walls. Phytochemistry (2001) 56:513-9. doi:10.1016/S0031-9422(00)00401-5
202. Zhao Z, Moghadasian MH. Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: a review. Food Chem (2008) 109:691-702. doi:10.1016/j.foodchem.2008.02.039
203. Srinivasan M, Sudheer AR, Pillai KR, Kumar PR, Sudhakaran PR, Menon VP. Influence of ferulic acid on gamma-radiation induced DNA damage, lipid peroxidation and antioxidant status in primary culture of isolated rat hepatocytes. Toxicology (2006) 228:249-58. doi:10.1016/j.tox.2006.09.004
204. Baskaran N, Manoharan S, Balakrishnan S, Pugalendhi P. Chemopreventive potential of ferulic acid in 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats. Eur J Pharmacol (2010) 637:22-9. doi:10.1016/j.ejphar.2010.03.054
205. Alias LM, Manoharan S, Vellaichamy L, Balakrishnan S, Ramachandran CR. Protective effect of ferulic acid on 7,12-dimethylbenz[a]anthracene-induced skin carcinogenesis in Swiss albino mice. Exp Toxicol Pathol (2009) 61:205-14. doi:10.1016/j.etp.2008.09.001
206. Janicke B, Hegardt C, Krogh M, Onning G, Akesson B, Cirenajwis HM, et al. The antiproliferative effect of dietary fiber phenolic compounds ferulic acid and p-coumaric acid on the cell cycle of Caco-2 cells. Nutr Cancer (2011) 63:611-22. doi:10.1080/01635581.2011.538486
207. Maurya DK, Devasagayam TP. Ferulic acid inhibits gamma radiation-induced DNA strand breaks and enhances the survival of mice. Cancer Biother Radiopharm (2013) 28:51-7. doi:10.1089/cbr.2012.1263
208. Li W, Guo J, Tang Y, Wang H, Huang M, Qian D, et al. Pharmacokinetic comparison of ferulic acid in normal and blood deficiency rats after oral administration of Angelica sinensis, Ligusticum chuanxiong and their combination. Int J Mol Sci (2012) 13:3583-97. doi:10.3390/ijms13033583
209. An C, Mou Z. Salicylic acid and its function in plant immunity. J Integr Plant Biol (2011) 53:412-28. doi:10.1111/j.1744-7909.2011.01043.x
210. Durner J, Shah J, Klessig DF. Salicylic acid and disease resistance in plants. Trends Plant Sci (1997) 2:266-74. doi:10.1016/S1360-1385(97)86349-2
211. Fuster V, Sweeny JM. Aspirin: a historical and contemporary therapeutic overview. Circulation (2011) 123:768-78. doi:10.1161/CIRCULATIONAHA.110.963843
212. Raskin I. Role of salicylic acid in plants. Annu Rev Plant Biol (1992) 43:439-63. doi:10.1146/annurev.pp.43.060192.002255
213. Vlot AC, Dempsey DA, Klessig DF. Salicylic acid, a multifaceted hormone to combat disease. Annu Rev Phytopathol (2009) 47:177-206. doi:10.1146/annurev.phyto.050908.135202
214. Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M, et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood (2008) 111:4880-91.
215. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 376:1741-50. doi:10.1016/S0140-6736(10)61543-7
216. Treutter D. Significance of flavonoids in plant resistance: a review. Environ Chem Lett (2006) 4:147-57. doi:10.1007/s10311-006-0068-8
217. Krolicka A, Szpitter A, Gilgenast E, Romanik G, Kaminski M, Lojkowska E. Stimulation of antibacterial naphthoquinones and flavonoids accumulation in carnivorous plants grown in vitro by addition of elicitors. Enzyme Microb Technol (2008) 42:216-21. doi:10.1016/j.enzmictec.2007.09.011
218. Lowry JB, Cook N, Wilson RD. Flavonol glycoside distribution in cultivars and hybrids of Leucaena leucocephala. J Sci Food Agric (1984) 35:401-7. doi:10.1002/jsfa.2740350407
219. Meckelmann SW, Riegel DW, Van Zonneveld MJ, Rios L, Pena K, Ugas R, et al. Compositional characterization of native Peruvian chili peppers (Capsicum spp.). J Agric Food Chem (2013) 61:2530-37. doi:10.1021/jf304986q
220. Stolarczyk M, Piwowarski JP, Granica S, Stefanska J, Naruszewicz M, Kiss AK. Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium Ellagitannins, Urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion. Phytother Res (2013). doi:10.1002/ptr.4941. [Epub ahead of print].
221. Tlili N, Elfalleh W, Saadaoui E, Khaldi A, Triki S, Nasri N. The caper (Capparis L.): ethnopharmacology, phytochemical and pharmacological properties. Fitoterapia (2011) 82:93-101. doi:10.1016/j.fitote.2010.09.006
222. Lv J, Yu L, Lu Y, Niu Y, Liu L, Costa J, et al. Phytochemical compositions, and antioxidant properties, and antiproliferative activities of wheat flour. Food Chem (2012) 135(2):325-31. doi:10.1016/j.foodchem.2012.04.141
223. Weston LA, Mathesius U. Flavonoids: their structure, biosynthesis and role in the rhizosphere, including allelopathy. J Chem Ecol (2013) 39:283-97. doi:10.1007/s10886-013-0248-5
224. Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett (2008) 269:315-25. doi:10.1016/j.canlet.2008.03.046
225. Boly R, Gras T, Lamkami T, Guissou P, Serteyn D, Kiss R, et al. Quercetin inhibits a large panel of kinases implicated in cancer cell biology. Int J Oncol (2011) 38:833-42. doi:10.3892/ijo.2010.890
226. Granado-Serrano AB, Martin MA, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr (2006) 136:2715-21.
227. Chuang-Xin L, Wen-Yu W, Yao C, Xiao-Yan L, Yun Z. Quercetin enhances the effects of 5-fluorouracil-mediated growth inhibition and apoptosis of esophageal cancer cells by inhibiting NF-kappaB. Oncol Lett (2012) 4:775-8.
228. Spagnuolo C, Cerella C, Russo M, Chateauvieux S, Diederich M, Russo GL. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. Br J Cancer (2011) 105:221-30. doi:10.1038/bjc.2011.229
229. Ekstrom AM, Serafini M, Nyren O, Wolk A, Bosetti C, Bellocco R. Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann Oncol (2011) 22:438-43. doi:10.1093/annonc/mdq390
230. Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res (1996) 2:659-68.
231. Barve A, Chen C, Hebbar V, Desiderio J, Saw CL, Kong AN. Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. Biopharm Drug Dispos (2009) 30:356-65. doi:10.1002/bdd.677
232. Manach C, Morand C, Crespy V, Demigne C, Texier O, Regerat F, et al. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett (1998) 426:331-6. doi:10.1016/S0014-5793(98)00367-6
233. Manach C, Morand C, Texier O, Favier ML, Agullo G, Demigne C, et al. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr (1995) 125:1911-22.
234. Sesink ALI, Arts C, de Boer VC, Breedveld P, Schellens JH, Hollman PC, et al. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol Pharmacol (2005) 67:1999-2006. doi:10.1124/mol.104.009753
235. Tian M, Bi W, Row KH. Simultaneous extraction and separation of flavonols and flavones from Chamaecyparis obtusa by multi-phase extraction using an ionic liquid-modified microsphere polymer. Phytochem Anal (2012) 23:576-81. doi:10.1002/pca.2357
236. Huang MT, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM, et al. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis (1983) 4:1631-7. doi:10.1093/carcin/4.12.1631
237. Morales P, Haza AI. Selective apoptotic effects of piceatannol and myricetin in human cancer cells. J Appl Toxicol (2012) 32:986-93. doi:10.1002/jat.1725
238. Shiomi K, Kuriyama I, Yoshida H, Mizushina Y. Inhibitory effects of myricetin on mammalian DNA polymerase, topoisomerase and human cancer cell proliferation. Food Chem (2013) 139:910-8. doi:10.1016/j.foodchem.2013.01.009
239. Phillips PA, Sangwan V, Borja-Cacho D, Dudeja V, Vickers SM, Saluja AK. Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Cancer Lett (2011) 308:181-8. doi:10.1016/j.canlet
240. Choi SJ, Shin SC, Choi JS. Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin. Arch Pharm Res (2011) 34:309-15. doi:10.1007/s12272-011-0217-x
241. Li C, Lim SC, Kim J, Choi JS. Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Eur J Drug Metab Pharmacokinet (2011) 36:175-82. doi:10.1007/s13318-011-0036-y
242. Chen ND, Chen NF, Chen CW, Zhang L. Separation and structure elucidation of a new homoflavanol derivative from Pteridium aquilinum (L.) Kuhn. Nat Prod Res (2013). doi:10.1080/14786419.2012.761618. [Epub ahead of print].
243. Tan C, Wang Q, Luo C, Chen S, Li Q, Li P. Yeast & #945;-glucosidase inhibitory phenolic compounds isolated from Gynura medica leaf. Int J Mol Sci (2013) 14:2551-8. doi:10.3390/ijms14022551
244. Chen AY, Chen YC. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem (2013) 138:2099-107. doi:10.1016/j.foodchem.2012.11.139
245. Luo H, Jiang B, Li B, Li Z, Jiang BH, Chen YC. Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. Int J Nanomedicine (2012) 7:3951-9. doi:10.2147/IJN.S33670
246. Li G, Zeng X, Xie Y, Cai Z, Moore JC, Yuan X, et al. Pharmacokinetic properties of isorhamnetin, kaempferol and quercetin after oral gavage of total flavones of Hippophae rhamnoides L. in rats using a UPLC-MS method. Fitoterapia (2012) 83:182-91. doi:10.1016/j.fitote.2011.10.012
247. Silva ID, Rodrigues AS, Gaspar J, Maia R, Laires A, Rueff J. Involvement of rat cytochrome 1A1 in the biotransformation of kaempferol to quercetin: relevance to the genotoxicity of kaempferol. Mutagenesis (1997) 12:383-90. doi:10.1093/mutage/12.5.383
248. An G, Gallegos J, Morris ME. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux. Drug Metab Dispos (2011) 39:426-32. doi:10.1124/dmd.110.035212
249. Li C, Li X, Choi JS. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats. Arch Pharm Res (2009) 32:133-8. doi:10.1007/s12272-009-1127-z
250. Luo H, Daddysman MK, Rankin GO, Jiang BH, Chen YC. Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int (2010) 10:16. doi:10.1186/1475-2867-10-16
251. Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov (2009) 8:33-40. doi:10.1038/nrd2781
252. DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev (2012) 246:379-400. doi:10.1111/j.1600-065X.2012.01099.x
253. Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch (2005) 446:475-82. doi:10.1007/s00428-005-1264-9
254. Delhalle S, Duvoix A, Schnekenburger M, Morceau F, Dicato M, Diederich M. An introduction to the molecular mechanisms of apoptosis. Ann N Y Acad Sci (2003) 1010:1-8. doi:10.1196/annals.1299.001
255. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144:646-74. doi:10.1016/j.cell.2011.02.013
256. Gray AI, Igoli JO, Edrada-Ebel R. Natural products isolation in modern drug discovery programs. In: Natural Products Isolation. Dordrecht: Springer (2012). p. 515-34.
257. Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science (2009) 325:161-5. doi:10.1126/science.1168243
258. Mora C, Tittensor DP, Adl S, Simpson AG, Worm B. How many species are there on Earth and in the ocean? PLoS Biol (2011) 9:e1001127. doi:10.1371/journal.pbio.1001127
259. Quinn RJ. Basics and principles for building natural product-based libraries for HTS. Chem Genomics (2012):87.
260. Zerikly M, Challis GL. Strategies for the discovery of new natural products by genome mining. Chembiochem (2009) 10:625-33. doi:10.1002/cbic.200800389
261. Lomenick B, Olsen RW, Huang J. Identification of direct protein targets of small molecules. ACS Chem Biol (2011) 6:34-46. doi:10.1021/cb100294v
262. Rix U, Superti-Furga G. Target profiling of small molecules by chemical proteomics. Nat Chem Biol (2009) 5:616-24. doi:10.1038/nchembio.216
263. Roti G, Stegmaier K. Genetic and proteomic approaches to identify cancer drug targets. Br J Cancer (2012) 106:254-61. doi:10.1038/bjc.2011.543
264. Chen L, Morrow JK, Tran HT, Phatak SS, Du-Cuny L, Zhang S. From laptop to benchtop to bedside: structure-based drug design on protein targets. Curr Pharm Des (2012) 18:1217-39. doi:10.2174/138161212799436386
265. Mihasan M. What in silico molecular docking can do for the 'bench-working biologists'. J Biosci (2012) 37:1089-95. doi:10.1007/s12038-012-9273-8
266. Ou-Yang SS, Lu JY, Kong XQ, Liang ZJ, Luo C, Jiang H. Computational drug discovery. Acta Pharmacol Sin (2012) 33:1131-40. doi:10.1038/aps
267. Kuhn M, Szklarczyk D, Franceschini A, von Mering C, Jensen LJ, Bork P. STITCH 3: zooming in on protein-chemical interactions. Nucleic Acids Res (2012) 40:D876-80. doi:10.1093/nar/gkr1011
268. Beutler JA. Natural Products as Tools for Discovering New Cancer Targets. In: Natural Products and Cancer Drug Discovery. Dordrecht: Springer (2013). p. 213-37.
269. Chiaradonna F, Moresco RM, Airoldi C, Gaglio D, Palorini R, Nicotra F, et al. From cancer metabolism to new biomarkers and drug targets. Biotechnol Adv (2012) 30:30-51. doi:10.1016/j.biotechadv.2011.07.006
270. Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, Shlomi T. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol (2011) 7:501. doi:10.1038/msb.2011.35
271. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov (2006) 5:993-6. doi:10.1038/nrd2199
272. Patel MN, Halling-Brown MD, Tym JE, Workman P, Al-Lazikani B. Objective assessment of cancer genes for drug discovery. Nat Rev Drug Discov (2013) 12:35-50. doi:10.1038/nrd3913